Torres Denice
SEC Form 4 insider trading activity
Torres Denice has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including SPTX, GKOS, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Nov 4, 2026.
On the most recent filing, Torres Denice is listed as Director at Seaport Therapeutics, Inc. Inside the rolling window, Torres Denice reported 1 open-market purchase totaling $99K in SPTX and no open-market sales.
Companies traded
Other insiders at SPTX
Insider Buying
$99K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Torres Denice made?
Torres Denice has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including SPTX, GKOS since 2026.
Which companies does Torres Denice trade?
Torres Denice has filed SEC Form 4 disclosures for 2 companies, including SPTX, GKOS.
When was Torres Denice's most recent SEC Form 4 filing?
Torres Denice's most recent SEC Form 4 filing on Tracefour is dated Nov 4, 2026.
What is Torres Denice's total buy and sell value in the current window?
Inside the rolling retention window, Torres Denice bought $99K and sold $0 based on SEC Form 4 filings.
What was Torres Denice's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,000 SPTX shares on 2026-11-03, worth $99K, per SEC Form 4 filings.